To support research & studies into infectious diseases, ProSci has reagents for the study of many viral disease agents inc. Covid, HIV, & Influenza.
Viral Infectious Diseases
SARS-CoV-2 (COVID-19) Mutations
As viruses create more of themselves, they mutate – single-point changes in genetic code. SARS-CoV-2 virus mutated to be more transmissible.
What is Cytokine Storm? – Cytokine Storm and COVID-19
The cytokine storm is a relatively new discovery & is actively being studied. ProSci offers cytokine & chemokine antibodies & recombinant proteins.
SARS-CoV-2 Open Reading Frames (ORFs)
The SARS-CoV-2 genome is ~29 kb divided into 10 ORFs. Each of these ORFs (except seemingly ORF10) is translated in 29 different proteins.
Immune Evasion of SARS-CoV-2
Research continues in understanding mechanisms of SARS-CoV-2 immune evasion. ProSci offers antibodies & recombinant proteins for SARS-CoV-2 research.
SARS-CoV-2 Recombinant Virus Lineages
ProSci has developed SARS-CoV-2 variant-specific reagents by focusing on unique point mutations in the spike protein.
The Role of Monoclonal Antibodies & Biosimilars in Life Science Research
mAbs (biosimilars) as tools to research novel new therapies and uncover effective off-target application.
Insights into the Molecular Mechanisms Regulating Necroptosis
This white paper details findings in molecular mechanisms that govern necroptosis related to RIPK & details #2283 use to analyse expression of RIPK3.
Exploring the Roles of RIPKs in Immune Responses, Inflammation, and Cell Death: Recent Findings
ProSci has 25+ years expertise in developing antibodies. This white paper details use of RIPK antibodies & findings on RIPKs in signalling pathways.
A Deep Dive into the Hidden Power of Programmed Cell Death: Unlocking Therapeutic Potential with Antibodies
ProSci has 25+ years of expertise in developing antibodies. This white paper details use of ProSci antibodies in the study of programmed cell death.